AI Article Synopsis
- DIY automated insulin delivery systems for type 1 diabetes utilize off-the-shelf glucose sensors and insulin pumps, connected through open source software, and their usage is on the rise, showing promising glucose management results.
- There are challenges related to data, education, policy, technology, and legal regulations that healthcare professionals, device manufacturers, and regulators must navigate due to the unregulated nature of these systems.
- A coordinated effort is necessary to address these obstacles, aiming to improve access to this technology for better glucose self-management for individuals with type 1 diabetes.
Article Abstract
Do-it-yourself automated insulin delivery systems for people living with type 1 diabetes use commercially available continuous glucose sensors and insulin pumps linked by unregulated open source software. Uptake of these systems is increasing, with growing evidence suggesting that positive glucose outcomes may be feasible. Increasing interest from people living with, or affected by, type 1 diabetes presents challenges to healthcare professionals, device manufacturers and regulators as the legal, governance and risk frameworks for such devices are not defined. We discuss the data, education, policy, technology and medicolegal obstacles to wider implementation of DIY systems and outline the next steps required for a co-ordinated approach to reducing variation in access to a technology that has potential to enable glucose self-management closer to target.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906512 | PMC |
| http://dx.doi.org/10.1038/s41746-019-0202-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!